POON CHRISTINE A
SEC Form 4 insider trading activity
POON CHRISTINE A has filed 4 SEC Form 4 filings (12 transaction rows) across 3 companies, including NBIX, PRU, REGN, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: May 21, 2026.
On the most recent filing, POON CHRISTINE A is listed as Director at REGENERON PHARMACEUTICALS, INC. Inside the rolling window, POON CHRISTINE A reported no open-market purchases and 1 open-market sale totaling $4.3M in REGN.
Companies traded
Other insiders at NBIX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4.3M
reported sales (SEC code S)
Companies
3
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has POON CHRISTINE A made?
POON CHRISTINE A has filed 4 SEC Form 4 filings (12 transaction rows) across 3 companies, including NBIX, PRU, REGN since 2025.
Which companies does POON CHRISTINE A trade?
POON CHRISTINE A has filed SEC Form 4 disclosures for 3 companies, including NBIX, PRU, REGN.
When was POON CHRISTINE A's most recent SEC Form 4 filing?
POON CHRISTINE A's most recent SEC Form 4 filing on Tracefour is dated May 21, 2026.
What is POON CHRISTINE A's total buy and sell value in the current window?
Inside the rolling retention window, POON CHRISTINE A bought $0 and sold $4.3M based on SEC Form 4 filings.
What was POON CHRISTINE A's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 6,500 REGN shares on 2025-10-29, worth $4.3M, per SEC Form 4 filings.